WHO Director General ‘Welcomes’ Costa Rica Call For Pooled Rights To COVID-19 Treatments; G-20 Pledges Broad Support To Emergency Response 26/03/2020 Elaine Ruth Fletcher World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has welcomed the call by Costa Rica’s President, Carlos Alvarado Quesada, for WHO to launch an initiative that would “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.” “I welcome his initiative & call for pooled rights […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Blood Plasma Of Recovered COVID-19 Patients Approved By US FDA For Investigational Use As Treatment 25/03/2020 Grace Ren The US Food and Drug Administration granted investigational emergency use approval for convalescent blood plasma as a potential COVID-19 treatment on Tuesday. Cloned antibodies from recovered COVID-19 patients showed impressive ability to neutralize SARS-CoV-2, the virus behind the disease, in cell cultures, according to a paper published Wednesday on the preprint server BioRxiv. Two of […] Continue reading -> WHO Announces New International Trial To Search For COVID-19 Treatments 18/03/2020 Editorial team The World Health Organization announced on Wednesday a global “SOLIDARITY Trial” to generate a large, robust study comparing potential treatments for COVID-19. Currently there are 522 trials listed on WHO’s Clinical Trial registry under “COVID-19.” “Multiple small trials with different methodologies may not give us the clear, strong evidence we need about which treatments help to […] Continue reading -> Europe Is New Epicentre Of COVID-19 Pandemic; FDA Approval of Roche High-Volume Diagnostic Could Accelerate Testing 13/03/2020 Elaine Ruth Fletcher & Grace Ren Europe has now become the epicenter of the COVID-19 pandemic, with more cases and deaths than the rest of the world combined, apart from China, said WHO Director General Dr Tedros Adhanom Ghebreyesus. Even more worrisome, there are now more new cases being reported everyday in Europe, which has a population of about 741 million […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Blood Plasma Of Recovered COVID-19 Patients Approved By US FDA For Investigational Use As Treatment 25/03/2020 Grace Ren The US Food and Drug Administration granted investigational emergency use approval for convalescent blood plasma as a potential COVID-19 treatment on Tuesday. Cloned antibodies from recovered COVID-19 patients showed impressive ability to neutralize SARS-CoV-2, the virus behind the disease, in cell cultures, according to a paper published Wednesday on the preprint server BioRxiv. Two of […] Continue reading -> WHO Announces New International Trial To Search For COVID-19 Treatments 18/03/2020 Editorial team The World Health Organization announced on Wednesday a global “SOLIDARITY Trial” to generate a large, robust study comparing potential treatments for COVID-19. Currently there are 522 trials listed on WHO’s Clinical Trial registry under “COVID-19.” “Multiple small trials with different methodologies may not give us the clear, strong evidence we need about which treatments help to […] Continue reading -> Europe Is New Epicentre Of COVID-19 Pandemic; FDA Approval of Roche High-Volume Diagnostic Could Accelerate Testing 13/03/2020 Elaine Ruth Fletcher & Grace Ren Europe has now become the epicenter of the COVID-19 pandemic, with more cases and deaths than the rest of the world combined, apart from China, said WHO Director General Dr Tedros Adhanom Ghebreyesus. Even more worrisome, there are now more new cases being reported everyday in Europe, which has a population of about 741 million […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Blood Plasma Of Recovered COVID-19 Patients Approved By US FDA For Investigational Use As Treatment 25/03/2020 Grace Ren The US Food and Drug Administration granted investigational emergency use approval for convalescent blood plasma as a potential COVID-19 treatment on Tuesday. Cloned antibodies from recovered COVID-19 patients showed impressive ability to neutralize SARS-CoV-2, the virus behind the disease, in cell cultures, according to a paper published Wednesday on the preprint server BioRxiv. Two of […] Continue reading -> WHO Announces New International Trial To Search For COVID-19 Treatments 18/03/2020 Editorial team The World Health Organization announced on Wednesday a global “SOLIDARITY Trial” to generate a large, robust study comparing potential treatments for COVID-19. Currently there are 522 trials listed on WHO’s Clinical Trial registry under “COVID-19.” “Multiple small trials with different methodologies may not give us the clear, strong evidence we need about which treatments help to […] Continue reading -> Europe Is New Epicentre Of COVID-19 Pandemic; FDA Approval of Roche High-Volume Diagnostic Could Accelerate Testing 13/03/2020 Elaine Ruth Fletcher & Grace Ren Europe has now become the epicenter of the COVID-19 pandemic, with more cases and deaths than the rest of the world combined, apart from China, said WHO Director General Dr Tedros Adhanom Ghebreyesus. Even more worrisome, there are now more new cases being reported everyday in Europe, which has a population of about 741 million […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Announces New International Trial To Search For COVID-19 Treatments 18/03/2020 Editorial team The World Health Organization announced on Wednesday a global “SOLIDARITY Trial” to generate a large, robust study comparing potential treatments for COVID-19. Currently there are 522 trials listed on WHO’s Clinical Trial registry under “COVID-19.” “Multiple small trials with different methodologies may not give us the clear, strong evidence we need about which treatments help to […] Continue reading -> Europe Is New Epicentre Of COVID-19 Pandemic; FDA Approval of Roche High-Volume Diagnostic Could Accelerate Testing 13/03/2020 Elaine Ruth Fletcher & Grace Ren Europe has now become the epicenter of the COVID-19 pandemic, with more cases and deaths than the rest of the world combined, apart from China, said WHO Director General Dr Tedros Adhanom Ghebreyesus. Even more worrisome, there are now more new cases being reported everyday in Europe, which has a population of about 741 million […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Europe Is New Epicentre Of COVID-19 Pandemic; FDA Approval of Roche High-Volume Diagnostic Could Accelerate Testing 13/03/2020 Elaine Ruth Fletcher & Grace Ren Europe has now become the epicenter of the COVID-19 pandemic, with more cases and deaths than the rest of the world combined, apart from China, said WHO Director General Dr Tedros Adhanom Ghebreyesus. Even more worrisome, there are now more new cases being reported everyday in Europe, which has a population of about 741 million […] Continue reading -> ‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘Sister’ Initiatives Commit US $129 Million to R&D for COVID-19 Vaccines & Cures; Funding To Manufacture Still A Barrier 11/03/2020 Grace Ren The Bill and Melinda Gates Foundation, Wellcome Trust, and Mastercard on Tuesday announced a US $125 million commitment of seed funding to a new COVID-19 Treatment Accelerator – whose aim as its name implies, will be to speed up the development of urgently needed drugs to treat people infected with COVID-19. Just hours later, the […] Continue reading -> International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
International Research Partnership & EDCTP To Invest €44m In Next-Gen Antimalarials To Combat Drug-Resistant Malaria In Africa 04/03/2020 Press release [Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Launched Digital Version Of Essential Medicines List 28/02/2020 Editorial team The World Health Organization launched the first-ever digital version of its latest Model list of Essential Medicines (EML) on Thursday. The move is the latest step in WHO’s effort to explore technology in a new focus on digital health. “For more than 40 years, the list has become a reliable and credible source of the most […] Continue reading -> Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Former Director Of Italian Medicines Agency Recognized For Drug Transparency Work 26/02/2020 Editorial team Former general director of the Italian Medicines Agency (AIFA) Luca Li Bassi was awarded the 2019 “International Transparency in Medicines Policies Awards” by the French civil society watchdog group l’Observatoire Médicaments Transparences (the Observatory for Transparency in Medicines), for his efforts in negotiating a milestone World Health Assembly resolution in May 2019 supporting more public […] Continue reading -> Posts navigation Older postsNewer posts